Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor
4.8
$ 9.00
In stock
(697)
Product Description
Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor
Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials
A conformation-selective monoclonal antibody against a small molecule-stabilised signalling-deficient form of TNF
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease
Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage - ScienceDirect
Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure–Activity Relationships and Molecular Docking
TNF Alpha Inhibitors Market Analysis, Trends, Size And Insights 2023 To 2032
Regulated Necrosis in Atherosclerosis Arteriosclerosis, Thrombosis, and Vascular Biology
Small molecule oral targeted therapies in ulcerative colitis - The Lancet Gastroenterology & Hepatology
Small-molecule modulators of tumor necrosis factor signaling - ScienceDirect
